We here demonstrate stable genetic engineering of mouse hematopoiesis with an Ifn‐γ transgene, whose expression is transcriptionally targeted to a subset of tumor‐infiltrating myeloid cells using a previously described and extensively characterized lentiviral vector platform (De Palma et al, 2008; Escobar et al, 2014, 2018). Here, IFNG is linked to neoplasm.